大うつ病の有効な翻訳モデルに近づいているのでしょうか?

Olivier Berton¹, Chang-Gyu Hahn, Michael E Thase

¹Department of Psychiatry, Center for Neurobiology and Behavior, University of Pennsylvania, Philadelphia, PA 19104, USA. bertonol@mail.med.upenn.edu

Science (New York, N.Y.)

|October 9, 2012

まとめ

鬱病の神経生物学を理解するには,より良い動物モデルが必要です. このレビューでは,うつ病の研究とその治療を改善し,ヒトの研究の限界を克服するための有望な臨床前研究戦略を強調しています.

科学分野:

神経科学は神経科学である.
精神科医は精神病を患っている.
薬理学薬理学とは

背景:

うつ病は,複雑な神経病理学と機能的不接続性を持つ広範囲にわたる障害です.
新興の治療法は,うつ病の神経生物学を理解するための新しい道を提供します.
ヒトの研究は,うつ病のメカニズムを解剖する際の実践的および倫理的な制限に直面しています.

研究の目的:

臨床前うつ病の研究における最近の進歩をレビューする.
うつ病の研究における発見のエンドポイントを改善するための戦略を強調する.
鬱病の現在の実験モデルを取り巻く懐疑論に対処するために.

主な方法:

臨床前うつ病モデルに関する現在の文献のレビュー.
新興の回路標的および急速発症の治療法の分析.
ヒトのうつ病症状と非人間生物の治療反応を模倣する戦略の評価.

主要な成果:

鬱病の神経病理学と接続障害を特徴づける進歩は加速しています.
うつ病の治療に新しい治療アプローチが生まれています.
鬱病の既存の臨床前モデルには,しばしば懐疑的な見方がある.

結論:

非人間モデルの改善は,うつ病神経生物学研究の進歩に不可欠です.
臨床前研究のエンドポイントの多様化と精錬は不可欠です.
継続的な進歩は,うつ病と治療への反応をモデル化するための革新的なアプローチに依存しています.

さらに関連する動画

05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

関連する概念動画

01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

01:29

Theoretical Approaches to Psychological Disorder

The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...

01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

01:03